You are here
- Home
- Therapy Areas
- Oncology/Infection
A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Children, Adolescents and Young Adults with Refractory CD22+ Acute Lymphoblastick Leukemia (ALL) or Non-Hodgkin's Lymphoma (NHL)
- Disease
- acute lymphocytic leukaemia, non-Hodgkin's lymphoma
- Drug Name
- CAT-8015
- Sponsor
- MedImmune
- Drug Status
- In Development
- Phase
- I
- Start Date
- Sep 29, 2008
- Study Name
- CAT-8015-1004
- Study Id
- CAT-8015-1004
- ClinicalTrials.gov ID
- NCT00659425
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
